Teoh Wendy H L, Sia Alex T H
Department of Women's Anesthesia, KK Women's and Children's Hospital, Singapore.
Anesth Analg. 2009 May;108(5):1592-8. doi: 10.1213/ane.0b013e31819e016d.
Spinal anesthesia for cesarean delivery may cause severe maternal hypotension, and a decrease in cardiac output (CO) and blood flow to the placenta. Fluid preloading with crystalloid is ineffective due to rapid redistribution. A "coload" given at the time of cerebrospinal fluid identification may be more effective. Our null hypothesis was that there would be no difference between the effect of a colloid preload (15 mL/kg hydroxyethyl starch (HES) 130/0.4 [Voluven 6%]) and an identical coload on maternal CO and the incidence of hypotension after spinal anesthesia for cesarean delivery. Secondary outcomes studied were neonatal acid- base status and predelivery vasopressor requirements.
Forty ASA PS I and II women scheduled for elective cesarean delivery were recruited. Patients were randomized to Group P (preload of 15 mL/kg HES) or Group C (coload, given when cerebrospinal fluid identified). Heart rate, arterial blood pressure, stroke volume and CO measurements were recorded at baseline, every minute for 10 min, and every 2.5 min interval for 10 min with the USCOM ultrasonic CO monitor. Spinal anesthesia was performed at the L3/4 interspace in the right lateral position. Arterial blood pressure was maintained at 90%-100% of baseline values using IV phenylephrine boluses.
Demographic, anesthetic, and surgical characteristics were similar. There were no between-group differences in baseline systolic blood pressure, heart rate, and colloid volume. CO and stroke volume were significantly increased in Group P (P = 0.01) in the 5 min after spinal anesthesia. This increase in CO was not sustained at 10 min. There were no significant between-group differences in the incidence of hypotension, absolute arterial blood pressure values (P = 0.73), predelivery median (range) phenylephrine requirements (300[0-1000] in Group P versus 150 [0-850]microg in Group C, P = 0.24), or neonatal outcome as measured by Apgar scores and umbilical arterial and venous blood gas values.
Intravascular volume expansion with 15 mL/kg HES 130/0.4 given as a preload, but not coload, significantly increased maternal CO for the first 5 min after spinal anesthesia for cesarean delivery, however, maternal and neonatal outcomes were not different.
剖宫产脊髓麻醉可能导致严重的产妇低血压,以及心输出量(CO)和胎盘血流减少。由于液体快速重新分布,晶体液预负荷无效。在脑脊液识别时给予“联合负荷量”可能更有效。我们的无效假设是,胶体预负荷(15 mL/kg羟乙基淀粉(HES)130/0.4 [万汶6%])与相同的联合负荷量对剖宫产脊髓麻醉后产妇的CO和低血压发生率的影响无差异。研究的次要结局是新生儿酸碱状态和分娩前血管升压药需求。
招募40例计划行择期剖宫产的ASA PS I和II级女性患者。患者随机分为P组(15 mL/kg HES预负荷)或C组(脑脊液识别时给予联合负荷量)。使用USCOM超声CO监测仪在基线、每分钟记录10分钟、每2.5分钟记录10分钟,记录心率、动脉血压、每搏量和CO测量值。在右侧卧位L3/4椎间隙进行脊髓麻醉。使用静脉注射去氧肾上腺素推注将动脉血压维持在基线值的90%-100%。
人口统计学、麻醉和手术特征相似。基线收缩压、心率和胶体量在组间无差异。脊髓麻醉后5分钟内,P组的CO和每搏量显著增加(P = 0.01)。CO的这种增加在10分钟时未持续。低血压发生率、绝对动脉血压值(P = 0.73)、分娩前去氧肾上腺素需求中位数(范围)(P组为300[0-1000]μg,C组为150 [0-850]μg,P = 0.24)或通过阿氏评分和脐动脉及静脉血气值测量的新生儿结局在组间无显著差异。
剖宫产脊髓麻醉后,以15 mL/kg HES 130/0.4作为预负荷而非联合负荷量进行血管内容量扩充,在最初5分钟内显著增加了产妇的CO,然而,产妇和新生儿结局并无差异。